LEHI If given a chance, who wouldnt want to spend a few bucks to find out if theyre at heightened risk for one day having to confront some life-changing or life-ending medical malady?
Thats the concept fueling an explosion in direct-to-consumer genetic testing and one thats also elevating ethical debates about how this most personal of information should be interpreted and protected.
Utah-born Ancestry.com is the latest entry into a growing list of companies offering health-focused genetic testing an industry expected to grow to $20 billion annually in the next few years.
While best known and an industry leader for its expertise in providing answers to the Where am I from? question, Ancestry will now expand its genetic testing resources to help people anticipate future health issues and help address, Whats going to make me sick?
Last week, the company that launched more than 30 years ago as a family history search service, later adding DNA testing to help customers identify their geographic ancestral roots, announced its new, health-focused genetic testing service.
AncestryHealth will offer two levels of genetic testing that the company said will deliver actionable insights that can empower people to take proactive steps in collaboration with their health care provider to address potential health risks identified in their genes and family health history.
Ancestry CEO Margo Georgiadis said the new genetic tests will help clients proactively manage their health care needs, armed with new insight on what conditions they may be predisposed for, based on genetic evidence.
Your genes dont need to be your destiny, Georgiadis said in a statement. Understanding your familial and inherited health risks can help you take action with your doctor to improve your chances of better health outcomes.
For more than three decades, Ancestry has empowered journeys of personal discovery to enrich lives. In the same way that knowledge of your family and ethnicity helps you understand your past to inspire your future, knowledge of your genetic health profile and any associated risks can help you be proactive in managing the future for you and your family.
The two testing products, according to the company, include AncestryHealth Core, which uses the companys current genotype genetic assessment technique to detect genetic differences and deliver personalized reports related to health conditions such as heart disease, hereditary cancers, blood-related disorders, and risks for carrier status of health conditions, such as Tay-Sachs disease. The one-time test costs $149 and also includes the companys family history report. Those who have already submitted a biologic sample to the company can get the new genetic report for $49.
While likely not available until sometime in 2020, the AncestryHealth Plus will use more current, genetic sequencing technology that will provide greater coverage of DNA differences for each condition and more risk categories such as those related to potentially developing heart disease, cancers, and disorders related to blood, the nervous system and connective tissues. The sequencing test will require a $199 activation fee, which the company said includes the first six months of membership and an additional $49 membership fee every six months. Existing Ancestry customers will be able to upgrade to AncestryHealth Plus for an initial payment of $49.
Ancestrys testing regimen will assess genetic samples and indicate predispositions for high cholesterol and cardiomyopathy, which can lead to heart disease; hereditary indicators for breast, ovarian, colon and uterine cancers; and blood disorders including abnormal clotting and iron overload. The testing can also determine if the sample donor is a gene carrier for cystic fibrosis, sickle-cell anemia or Tay-Sachs disease, a fatal nervous system disorder that most commonly occurs in children.
Unlike its competitor, 23andMe, which has earned U.S. Food and Drug Administration approval for providing genetic test results directly to customers without a physicians participation, Ancestrys genetic testing service requires a physicians order to conduct the tests and the company says it has contracted with a private network of independent physicians and genetic counselors who participate in the process. Ancestrys health testing service also connects customers to educational information, including access to genetic counseling resources and provides printable and consumer and physician-ready reports that provide guidance for next steps an individual and their health care provider can take together.
Lynn Jorde, chairman of the University of Utahs Department of Human Genetics and executive director of the Utah Genome Project, said while labs are now capable of sequencing the entirety of the human genome some 3 billion genetic basis pairs the microarray technique currently used by Ancestry evaluates a small window of genes that, if a variation is found, have a viable medical response.
What theyre looking at is specific changes in the DNA that we know about in specific instances ... and are often called actionable genes, Jorde explained. If you have a disease causing variant here, there is actually something we can do about it.
Jorde said while some genetic markers, like those for cystic fibrosis, indicate a high probability that you have or will develop that condition, many more are merely suggestive.
The predictive power of genetic testing is getting better and better, but it will never be perfect, Jorde said. For many of these conditions, there are nongenetic components that impact risk.
Jorde said things like environment, diet and exercise/activity level can play a significant role in an individuals risk of developing an illness or disease.
Teneille Brown is a professor at the University of Utahs S.J. Quinney College of Law and an expert in health law and medical ethics. In an interview, she noted direct-to-consumer genetic testing services, now being offered by dozens of companies according to the National Institute of Health, are occupying a space thats in between current regulatory boundaries aimed at protecting individuals privacy rights.
In the research realm, any federally funded projects are subject to stringent privacy rules, Brown said. That is also the case for health care institutions that handle genetic material, under (Health Insurance Portability and Accountability Act) rules.
But the big databases being built by testing companies are outside of the federal funding process and are not health care providers, so the HIPAA rules dont apply, Brown said.
Ancestry appears to underscore this by noting, in its user agreement, that it is not a covered entity under HIPAA rules.
Brown noted that in addition to unanswered questions about privacy protections, genetic test results can lead to deep emotional impacts for tested individuals, either through the discovery of gene markers that are suggestive of some future medical challenge or, less obviously, when a clean test is returned, which may provide an inaccurate suggestion that theres nothing to worry about.
Theres a huge problem when it comes to understanding what these risk scores mean, Brown said. The predictive values of these results is widely variable, including what is, or is not, implied by failure to find a specific marker.
Brown said genetic testing companies have wide-ranging policies regarding sharing an individuals genetic test results or stored biologic samples with third-party researchers. Ancestry, for example, says it will only share your information if youve given them specific permission to do so, through its informed consent agreement.
While the regulatory world is lagging behind the fast-moving development of genetic testing technology, Brown said she believes the bigger companies, including Ancestry, are working to create appropriate protections for their customers. And, she added, the growing body of knowledge being accumulated by this work could lead to groundbreaking advancements in treatments for serious diseases.
These companies might play a role in developing amazing drugs and therapies, Brown said. Collectively, they are adding all of this amazing content, providing pedigrees and information and incredibly powerful databases ... and a lot of good can come of it.
Its not at all sinister, but we need consumers to know what theyre submitting and being diligent about potential secondary uses of that data. More robust consent requirements for users and strict limitations for secondary uses are certainly in order.
- Yann Joly on the fight against genetic discrimination - McGill Reporter - April 2nd, 2020
- Science to the rescue? How modern genetics could help save the world from coronavirus - Genetic Literacy Project - April 2nd, 2020
- Oldest human genetic data gleaned from 1.8-million-year-old tooth Haaretz - News Collective - April 2nd, 2020
- Science to the rescue? How modern genetics could help save the world from coronavirus - Alliance for Science - Alliance for Science - April 2nd, 2020
- BHU department claims to have discovered new technology to test COVID-19 - Jagran Josh - April 2nd, 2020
- Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights - BioSpace - April 2nd, 2020
- Researchers at U of T developing antibodies to 'neutralize' novel coronavirus before it invades cells - News@UofT - April 2nd, 2020
- What is coronavirus and Covid-19? An explainer - KTVZ - April 2nd, 2020
- Plasmid Market was Valued at US$ 89.52 million in 2018 and is Estimated to Reach US$ 447.68 Million by 2027, growing at a CAGR of 19.5% over the... - April 2nd, 2020
- The genetic architecture of the human cerebral cortex - Science Magazine - March 26th, 2020
- The Coronavirus Pandemic Shows Us The Importance Of Combatting Climate Change - Forbes - March 26th, 2020
- Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis - P&T... - March 26th, 2020
- IN CONSERVATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS - BioBuzz - March 26th, 2020
- How healthtech startup Bione aims to use genetic testing in the fight against coronavirus - YourStory - March 26th, 2020
- Coronavirus: Massive gap in US response revealed after scientists learn colleague tested positive through twee - MEAWW - March 26th, 2020
- Avera announces ability to test for COVID-19 in South Dakota - The Dickinson Press - March 24th, 2020
- University of Utah experts advise caution over drugs hyped as possible coronavirus treatments - Salt Lake Tribune - March 24th, 2020
- Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the US and Canada - PRNewswire - March 24th, 2020
- Studying the African genome could yield new medical treatments for everyone - Genetic Literacy Project - March 24th, 2020
- Human Genetics Market Higher Growth Rate / CAGR over the Forecast Period to 2026 by Key Players like QIAGEN, Agilent Technologies, Illumina - New Day... - March 16th, 2020
- Coronavirus is hard on older people and scientists aren't sure why - NBCNews.com - March 16th, 2020
- Researchers study irregular horse heartbeats, hoping to find a cure - Minnesota Daily - March 16th, 2020
- Dr. John T. Macdonald Foundation seeking to fund community-based organizations with major grant dollars - Miami's Community Newspapers - March 16th, 2020
- A book that could save lives: Adam Rutherford's How to Argue with a Racist reviewed - Spectator.co.uk - March 16th, 2020
- Validea's Top Five Healthcare Stocks Based On Motley Fool - 3/15/2020 - Nasdaq - March 16th, 2020
- Fighting the coronavirus outbreak with genetic sequencing, CRISPR and synthetic biology - Genetic Literacy Project - March 16th, 2020
- human genetics | Description, Chromosomes, & Inheritance ... - February 29th, 2020
- Human Genetics | Pitt Public Health | University of Pittsburgh - February 29th, 2020
- Amgen To Present At The Cowen 40th Annual Healthcare Conference - BioSpace - February 29th, 2020
- Working on 'the human side' of heritable cancers - Penn: Office of University Communications - February 29th, 2020
- Ancient Scotsman with Protruding Rear End Found Carved on Monolith - The Vintage News - February 29th, 2020
- Her parents taught her grit, caring for others. She's using those traits to fight heart disease. - Thrive Global - February 29th, 2020
- IFFGD Raises Awareness for Rare Digestive Diseases on Rare Disease Day 2020 - P&T Community - February 29th, 2020
- Research on intermittent fasting shows health benefits - National Institute on Aging - February 29th, 2020
- When a Supervolcano Erupted, These Ancient People Survived the Blankets of Ash - Discover Magazine - February 29th, 2020
- Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge - CCN.com - February 29th, 2020
- Stone tools show humans in India survived the cataclysmic Toba eruption 74,000 years ago - Firstpost - February 29th, 2020
- Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics - Noozhawk - January 19th, 2020
- Genetic testing firm 23andMe is first to create a drug using its customers' DNA - The Times - January 19th, 2020
- Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium - P&T Community - January 19th, 2020
- 11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why - SciTechDaily - January 19th, 2020
- Transposons Identified as Likely Cause of Undiagnosed Diseases - The Scientist - January 19th, 2020
- Do genetic ancestry tests know if you're Palestinian? A cautionary tale of race and science - ABC News - January 19th, 2020
- Controlling Our Own Evolution: What is the Future of Gene-Editing? - The Globe Post - January 19th, 2020
- There is a new player in adult bone healing - Baylor College of Medicine News - January 19th, 2020
- Air Pollution, Evolution, and the Fate of Billions of Humans - The New York Times - January 19th, 2020
- A New York Times column on 'Jewish genius' draws criticism for linking to a debunked University of Utah study - Salt Lake Tribune - January 5th, 2020
- Ambroxol Reverses Bone Damage in Girl With GD Type 1, Case Study Shows - Gaucher Disease News - January 5th, 2020
- Gene editing breakthroughs that cured genetic diseases in 2019 - The Star Online - January 5th, 2020
- Digid8 and the Emergence of DNA Matchmaking - Study Breaks - January 5th, 2020
- Etched in DNA: Decoding the secrets of the past - Christian Science Monitor - January 5th, 2020
- The Face of Science - Clemson World magazine - January 5th, 2020
- Aborting Babies Because They're Gay: Coming Soon to China - Patheos - January 5th, 2020
- Mutants among us: "Natural short sleepers" reveal the genetics of sleep - Inverse - January 5th, 2020
- The End of Infertility Is in Sight - UCSF News Services - January 5th, 2020
- Who is a Jew? DNA home testing adds new wrinkle to age-old debate - The Jewish News of Northern California - December 1st, 2019
- Humans and autoimmune diseases continue to evolve together - Medical News Today - December 1st, 2019
- Mutations in emerging autism gene tied to distinct traits - Spectrum - December 1st, 2019
- Gail Fisher's 'Dog Tracks': Spoiling you dog with extra food could cut short its life - The Union Leader - December 1st, 2019
- In a Wisconsin village, the doctor makes house calls and sees the rarest diseases on Earth - USA TODAY - December 1st, 2019
- Alzheimer's and Autism: Researchers Pinpoint Genetic Mutations Overlapping in Both Diseases - Being Patient - December 1st, 2019
- How do consumer DNA tests from the US and China stack up? - Abacus - December 1st, 2019
- Is Nature vs. Nurture an Outdated Concept? - The National Interest Online - December 1st, 2019
- Collection of genetic data leads to privacy concerns - The New Economy - December 1st, 2019
- Is sexual orientation genetic? Yes and no, an extensive study finds - Haaretz - November 19th, 2019
- Sexual orientation cannot be changed at will, lawyers argue - The Straits Times - November 19th, 2019
- Adam and Eve Are Possible: A Second Bite at the Genetic Apple - Christianheadlines.com - November 19th, 2019
- InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and... - November 19th, 2019
- How maternal Zika infection results in newborn microcephaly - Baylor College of Medicine News - November 19th, 2019
- Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform - Endpoints News - November 19th, 2019
- Sexual orientation cannot be wilfully changed, say lawyers fighting to repeal Section 377A - The Straits Times - November 19th, 2019
- The American Heart Association's Annual Conference Comes to Philly This Weekend - Philadelphia magazine - November 19th, 2019
- Clear link between genetics and depressive symptoms uncovered - The Age - November 19th, 2019
- At-Home DNA Tests Still Need the 'Human Touch,' Say Panelists at Genomics Roundtable Workshop - National Academies of Sciences, Engineering, and... - November 19th, 2019
- How in utero Zika virus infection can lead to microcephaly in newborns: Baylor research - Outbreak News Today - November 19th, 2019
- Taller People have Increased Risk of Irregular Heartbeat - News18 - November 19th, 2019
- In Down syndrome mouse model, scientists reverse intellectual deficits with drugs - University of California - November 19th, 2019
- Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results - GlobeNewswire - November 19th, 2019
- One of the World's Greatest Geneticists, He Gave Up British Citizenship for India - The Better India - November 19th, 2019
- Section 377A constitutional challenge: Expert evidence reveal sexual orientation cannot be changed at will, lawyers argue - The Online Citizen - November 19th, 2019